Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)-Reference-Cited by-同舟云学术

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

Published:2007-02 Issue:2 Volume:18 Page:324-330
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Comella P.,Filippelli G.,De Cataldis G.,Massidda B.,Frasci G.,Maiorino L.,Putzu C.,Mancarella S.,Palmeri S.,Cioffi R.,Roselli M.,Buzzi F.,Milia V.,Gambardella A.,Natale D.,Bianco M.,Ghiani M.,Masullo P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/2/324/696629/mdl396.pdf

Reference35 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patient data from 52 randomised clinical trials;Non-small Cell Lung Cancer Cooperative Group;BMJ,1995

2. Chemotherapy vs supportive care in advanced non-small cell lung cancer: results of a meta-analysis of the literature;Marino;Chest,1994

3. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough?;Grilli;J Clin Oncol,1993

4. Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life;Cullen;J Clin Oncol,1999

5. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life;Spiro;Thorax,2004

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases;Molecules;2022-04-11

2. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy;Clinical Immunology;2018-08

3. Metabolic vulnerability of cisplatin‐resistant cancers;The EMBO Journal;2018-06-06

4. Algorithm for the Treatment of Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer: An Evidence-Based Overview;Current Oncology;2018-06-01

5. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non–Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older;Clinical Lung Cancer;2017-09